e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Pulmonary hypertension in hypoxic lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The influence of right ventricular diastolic functions and pulmonary hypertension on exercise limitation and their relationship with serum NT-proBNP levels in COPD
T. Sahin Ozdemirel, B. Yetis, N. Bayraktar, S. Savas Bozbas, E. Karacaglar, G. Ulubay (Ankara, Turkey)
Source:
Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Session:
Pulmonary hypertension in hypoxic lung disease
Session type:
Thematic Poster Session
Number:
2366
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Sahin Ozdemirel, B. Yetis, N. Bayraktar, S. Savas Bozbas, E. Karacaglar, G. Ulubay (Ankara, Turkey). The influence of right ventricular diastolic functions and pulmonary hypertension on exercise limitation and their relationship with serum NT-proBNP levels in COPD. Eur Respir J 2011; 38: Suppl. 55, 2366
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Left ventricular diastolic function in patients with high altitude-induced pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 98s
Year: 2002
Τhe influence of pulmonary disease on ventricular diastolic dysfunction in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 539s
Year: 2003
Clinical significance of right ventricular diastolic dysfunction in pulmonary arterial hypertension
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005
In pulmonary hypertension changes in right ventricular ejection fraction better predict mortality than changes in pulmonary vascular resistance
Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Year: 2010
Plasma VEGF correlates with right ventricular function in pulmonary hypertension
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Sequential analysis of right ventricular function and exercise capacity in pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019
Association of intrinsic right ventricular function with exercise tolerance and ventilatory efficiency in pulmonary arterial hypertension
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018
Right ventricular diastolic function in high altitude pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 99s
Year: 2002
Increased right ventricular systolic:diastolic duration ratiopredicts mortality in idiopathic pulmonary arterial hypertension
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018
Cardiac function during exercise in pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise in pulmonary hypertension
Year: 2005
Diagnosis of left ventricular diastolic dysfunction using echocardiography in COPD patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricular diastolic dysfunction in stable COPD in relation to disease severity
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 49 (6) 1601419; 10.1183/13993003.01419-2016
Year: 2017
Among patients who have had a PE, left ventricular diastolic dysfunction is an unusual cause of exercise limitation
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019
Improved right ventricular function after substantial afterload reduction in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012
NT-pro-BNP levels are independent of exercise in pulmonary hypertension
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension
Source: Eur Respir J 2015; 45: 1603-1612
Year: 2015
Right ventricular ejection fraction and NT-proBNP are both indicators of wall stress in pulmonary hypertension
Source: Eur Respir J 2007; 29: 622-623
Year: 2007
Left ventricle diastolic dysfuntion in severe COPD and exercise tolerance
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Cardio-pulmonary-exercise testing, stress-induced right ventricular diastolic dysfunction and exercise capacity in non-severe chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept